Abstract Background Coronavirus Disease-19 (COVID-19) is associated with a high rate of
thrombosis, the pathophysiology of which is not well defined. Viscoelastic testing may …

Hypercoagulability and thrombosis remain a challenge to diagnose and treat in severe
COVID-19 infection. The ability of conventional global coagulation tests to accurately reflect …

Background: Viscoelastic coagulation testing has been suggested to help manage
coagulopathy in critically ill patients with COVID-19. However, results from different …

Background A high number of thrombotic complications have been reported in critically ill
patients with coronavirus disease 2019 (COVID-19) and appear to be related to a …

COVID 19 is associated with a hypercoagulable state and frequent thromboembolic
complications. For how long this acquired abnormality lasts potentially requiring preventive …

Background SARS-CoV-2 infections are suspected to trigger the coagulation system through
various pathways leading to a high incidence of thromboembolic complications …

BACKGROUND Critically ill coronavirus disease 2019 (COVID-19) patients have frequent
thrombotic complications and laboratory evidence of hypercoagulability. The relationship of …

In late December 2019 an outbreak of a novel coronavirus (SARS-CoV-2) causing severe
pneumonia (COVID-19) was reported in Wuhan, Hubei Province, China. A common finding …

Objective: Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection may
yield a hypercoagulable state with fibrinolysis impairment. We conducted a single-center …

Coagulation abnormalities were common findings in critically ill patients affected by
coronavirus infection disease (COVID)-19 and often correlated to more severe illness and …